Brief: Abingworth Llp Reports 7.7% Stake In Reneo Pharmaceuticals Inc As Of April 13, 2021 - SEC Filing
April 20 (Reuters) - Reneo Pharmaceuticals Inc RPHM.O :
* ABINGWORTH LLP REPORTS 7.7% STAKE IN RENEO PHARMACEUTICALS
INC
AS OF APRIL 13, 2021 - SEC FILING
Source text for Eikon: [https://bit.ly/2P5d3Un]
Further company coverage: RPHM.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Onkure Therapeutics
See all newsBrief: Onkure Therapeutics Inc Files For Mixed Shelf Of Up To $200 Million - SEC Filing
Onkure Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Onkure Therapeutics Inc reports results for the quarter ended March 31 - Earnings Summary
Onkure Therapeutics Inc expected to post a loss of $1.46 a share - Earnings Preview
U.S. RESEARCH ROUNDUP-F5, Nextracker, Stryker